BIO International Convention 2027

The BIO International Convention 2027 will take place from June 7 to 10, 2027, in Philadelphia (United States). Organized by the Biotechnology Innovation Organization (BIO), it is one of the leading international events for the biotechnology sector, bringing together thousands of professionals, companies, investors and representatives of the global life sciences ecosystem every year.

The BIO International Convention is one of the leading international platforms for partnering, business development and investment in biotechnology. Each edition brings together around 20,000 professionals and industry leaders from around the world, including biotechnology and pharmaceutical companies, startups, research centers, universities, investors, nonprofit organizations and public-sector representatives.

The event combines an extensive content program with BIO Partnering™, company presentations, a large exhibition area featuring more than 1,500 exhibitors, and numerous networking opportunities. The partnering platform enables participants to identify potential partners and schedule one-to-one meetings to foster new collaborations, business opportunities and investment.

The 2027 edition returns to Philadelphia, one of the leading biotechnology hubs in the United States and an ecosystem particularly strong in areas such as cell and gene therapies, precision medicine and the development of new healthcare solutions.

ICEX has opened a call for Spanish companies to participate in the Spain Pavilion at the BIO International Convention 2027.

Participation in the Spain Pavilion will enable companies to have their own presence at the event and access different participation options, including workspaces, access to the partnering system and services linked to business meetings.

ICEX will also provide participating companies with support to gain a better understanding of the U.S. biotechnology ecosystem, prepare their commercial strategy and establish connections with medical centers, universities, institutions, pharmaceutical companies, investors and other sector stakeholders.

The call is aimed, among others, at companies operating in health biotechnology, pharmaceuticals, artificial intelligence and big data applied to healthcare, bioinformatics, genomics, CRO/CMO services and other activities related to biotechnology and health.

Application deadline: February 23, 2027, at 3:00 pm.